Pricing

Synklino

21 people · 0 jobs

‌

Synklino is a developer of a CMV-specific immunotoxin intended to eradicate the cytomegalovirus infection.

Industries

Biotechnology, Health Care

Headquarters

Lyngby, Denmark

Employees

Links

Org chart

CEO & Co-Founder

Collapse

Jette Wagtberg Sen

COO

Carit Jacques Andersen

CFO

Josefin-Beate Holz

CMO

Head of Pharmacology

Chief Medical Officer

Dagmar Fæster Kildedal

Industrial Phd Student

Board & advisors

Mette Rosenkilde

Co-Founder & Board Member

Chairman

Morten Schrøder

Board Member

Board Member

Thomas Feldthus

Board Member

Christine Flarup Møller-Jensen

Board Member

Mads Lacoppidan

Board Member

Scientific Advisor

Scientific Advisor

Scientific Advisor

Teams

Board of Directors

10 people · 0 jobs

Leadership Team

5 people · 0 jobs

Scientific Team

3 people · 0 jobs

Advisory Team

3 people · 0 jobs

Offices

HQ
5 people · 0 jobs
AD
+1

Similar companies

Bavarian Nordic

8 followers

Tango Therapeutics

3 followers

Merck

282 followers

Cellares

4 followers

Function Health

12 followers

Revvity

9 followers

Visma Dinero

33 followers

Sanofi

281 followers

Gilead Sciences

159 followers

Regeneron

130 followers

AtriCure

4 followers

Explore companies